 | Up a level |
Mózes, Ferenc E; Lee, Jenny A; Vali, Yasaman; Selvaraj, Emmanuel A; Jayaswal, Arjun N A; Boursier, Jérôme; de Lédinghen, Victor; Lupșor-Platon, Monica; Yilmaz, Yusuf; Chan, Wah-Kheong; Mahadeva, Sanjiv; Karlas, Thomas; Wiegand, Johannes; Shalimar, Shalimar; Tsochatzis, Emmanouil; Liguori, Antonio; Wong, Vincent Wai-Sun; Lee, Dae Ho; Holleboom, Adriaan G; van Dijk, Anne-Marieke; ... (2024). Diagnostic accuracy of non-invasive tests to screen for at-risk MASH-An individual participant data meta-analysis. (In Press). Liver international Wiley 10.1111/liv.15914
Garcia-Tsao, Guadalupe; Bosch, Jaime; Kayali, Zeid; Harrison, Stephen A; Abdelmalek, Manal F; Lawitz, Eric; Satapathy, Sanjaya K; Ghabril, Marwan; Shiffman, Mitchell L; Younes, Ziad H; Thuluvath, Paul J; Berzigotti, Annalisa; Albillos, Agustin; Robinson, James M; Hagerty, David T; Chan, Jean L; Sanyal, Arun J (2020). Randomized Placebo-Controlled Trial of Emricasan in Non-alcoholic Steatohepatitis (NASH) Cirrhosis with Severe Portal Hypertension. Journal of hepatology, 72(5), pp. 885-895. Elsevier 10.1016/j.jhep.2019.12.010
Puoti, Massimo; Foster, Graham R; Wang, Stanley; Mutimer, David; Gane, Edward; Moreno, Christophe; Chang, Ting Tsung; Lee, Samuel S; Marinho, Rui; Dufour, Jean-François; Pol, Stanislas; Hezode, Christophe; Gordon, Stuart C; Strasser, Simone I; Thuluvath, Paul J; Zhang, Zhenzhen; Lovell, Sandra; Pilot-Matias, Tami; Mensa, Federico J (2018). High SVR12 with 8-week and 12-week glecaprevir/pibrentasvir therapy: An integrated analysis of HCV genotype 1-6 patients without cirrhosis. Journal of hepatology, 69(2), pp. 293-300. Elsevier 10.1016/j.jhep.2018.03.007
